Nucleic Acid Labeling Market Forecasts to 2028 – Global Analysis By Product (Services, Instruments), Application (Microarray, In Situ Hybridization), End User (Research Centers, Diagnostic Centers), and By Geography
According to Stratistics MRC, the Global Nucleic Acid Labeling market is accounted for $2,114.25 million in 2020 and is expected to reach $4,768.02 million by 2028 growing at a CAGR of 10.7% during the forecast period. Some of the key factors propelling the market growth include increasing healthcare expenditure, increase in research and development expenditure, rise in research activities specifically in genomic research and disease diagnosis, advancements in tools for synthetic genome design, and growing demand for personalized medicine.However, lack of skilled professionals in transcriptomics is restraining the market growth.
Labeling of nucleic acids is required for multiple studies proposing to elucidate their functions and dynamics in vitro and in cells. Nucleic acids can be transformed with labels that enable their detection or purification. The resulting nucleic acid probes can be used to recognize or recover other interacting molecules. Common labels used to produce nucleic acid probes include radioactive phosphates, biotin, fluorophores, and enzymes. There are several chemical and enzymatic methods prepared for labeling nucleic acids, such as the incorporation of fluorescent tags, radioactive phosphates, and modifications with biotin, which are essentially utilized in biotechnology applications. The labeled nucleic acid is used for purposes including PCR, FISH, blotting, microarrays, DNA sequencing, and in situ hybridization.
By product, biotin-based segment is expected to be the fastest-growing segment during the forecast period, due to increased stability and their non-hazardous nature. The biotin-based labels use non-toxic materials and have faster detection rates than radioactive probes. Furthermore, owing to their long half-life and high stability, biotin-based probes can be prepared in bulk and stored at -20°C for repeated uses. There have been several advancements in biotin-based techniques, such as the addition of long tails of biotinylated nucleotides through enzymatic methods to counter the technique’s limitations.
On the basis of geography, the Asia Pacific market is expected to expand at the fastest growth rate during the forecast period, due to the emergence of local players and the increasing penetration of key players in the Asia Pacific region. The emerging companies are tapping on the opportunities by providing a wide array of labeling solutions in developing nations. Moreover, an increase in the number of inter-regional collaborations among key entities has been witnessed in this region, further propelling the market growth. These collaborations are largely being targeted towards the enhancement of nucleic acid profiling services and genomic research across the Asia Pacific countries.
Some of the key players in Nucleic Acid Labeling Market include GE Healthcare, Promega Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Enzo Biochem Inc., New England Biolabs, PerkinElmer, Inc., F. Hoffmann La-Roche AG, Merck KGaA, Vector Laboratories Inc., Marker Gene Technologies Inc., VWR International, LLC, LubioScience GmbH, Helix OpCo LLC, and Interchim.
Estimated Market Size in 2020:
USD 2,114.25 million
Compound Annual Growth Rate (CAGR) from 2020 to 2028:
Predicted 2028 Value:
USD 4,768.02 million
Tables, Graphs & Figures
Labeling Technique, Product, Application, End User, Treatment Type, Type, Method, Sales Channel and Region
Core Drivers and Opportunities:
Restraining Factors & Market Threats:
Labeling Techniques Covered:
• Random Primer
• Nick Translation
• In Vitro Transcription
• End Labeling
• Reverse Transcription
• Terminal labeling
• Reagents & Kits
• Southern & Northern Blotting
• Fluorescence in Situ Hybridization (FISH)
• In Situ Hybridization
• Deoxyribonucleic Acid (DNA) Sequencing
• Polymerase Chain Reaction (PCR)
• Oligonucleotide Labeling
• Cellular Localization
End Users Covered:
• Research Centers
• Diagnostic Centers
• Academic & Research Institutes
• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies
• Testing Institutions
Treatment Types Covered:
• Ribonucleic Acid (RNA) Labeling
• Deoxyribonucleic Acid (DNA) Labeling
Sales Channels Covered:
• Direct Sales
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Key Questions Answered In The Report
The Global Nucleic Acid Labeling Market is majorly driven by increasing disease diagnosis, growing healthcare expenditure impacting personalized health technologies, increase in genomics research, and growth in R&D spending.
The biotin-based segment is growing at a highest CAGR owing to increased stability and their non-hazardous nature.
North America dominated with a significant market share due to the factors such as increase in personalized medicines, identifying the genetic modifications and therapeutic areas across the region.
Asia Pacific market is growing at a highest CAGR owing to the development of local players and the growing penetration of key players in the region.
Key players in Nucleic Acid Labeling Market include GE Healthcare, Promega Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Enzo Biochem Inc., New England Biolabs, PerkinElmer, Inc., F. Hoffmann La-Roche AG, Merck KGaA, Vector Laboratories Inc., Marker Gene Technologies Inc., VWR International, LLC, LubioScience GmbH, Helix OpCo LLC, and Interchim.
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.